Annual Operating Expenses
$13.93 M
+$1.83 M+15.08%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual total operating expenses is $13.93 million, with the most recent change of +$1.83 million (+15.08%) on December 31, 2022.
- During the last 3 years, NAVB annual operating expenses has risen by +$2.95 million (+26.85%).
- NAVB annual operating expenses is now -66.21% below its all-time high of $41.23 million, reached on December 31, 2007.
Performance
NAVB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.13 M
-$296.40 K-12.21%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly total operating expenses is $2.13 million, with the most recent change of -$296.40 thousand (-12.21%) on September 30, 2023.
- Over the past year, NAVB quarterly operating expenses has dropped by -$296.40 thousand (-12.21%).
- NAVB quarterly operating expenses is now -94.21% below its all-time high of $36.82 million, reached on December 31, 2007.
Performance
NAVB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NAVB Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +15.1% | -12.2% |
3 y3 years | +26.9% | -12.2% |
5 y5 years | -0.4% | -12.2% |
NAVB Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +15.1% | -55.8% | at low |
5 y | 5-year | at high | +28.6% | -55.8% | at low |
alltime | all time | -66.2% | +480.5% | -94.2% | +162.7% |
Navidea Biopharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $2.13 M(-12.2%) |
Jun 2023 | - | $2.43 M(+0.2%) |
Mar 2023 | - | $2.42 M(-23.1%) |
Dec 2022 | $13.93 M(+15.1%) | $3.15 M(-34.7%) |
Sep 2022 | - | $4.82 M(+64.7%) |
Jun 2022 | - | $2.93 M(-1.7%) |
Mar 2022 | - | $2.98 M(-18.2%) |
Dec 2021 | $12.11 M(+11.8%) | $3.64 M(+49.7%) |
Sep 2021 | - | $2.43 M(-9.4%) |
Jun 2021 | - | $2.68 M(-20.0%) |
Mar 2021 | - | $3.35 M(+16.1%) |
Dec 2020 | $10.83 M(-1.4%) | $2.89 M(-0.6%) |
Sep 2020 | - | $2.91 M(+23.7%) |
Jun 2020 | - | $2.35 M(-12.5%) |
Mar 2020 | - | $2.69 M(-3.2%) |
Dec 2019 | $10.98 M(-0.8%) | $2.77 M(-10.2%) |
Sep 2019 | - | $3.09 M(+14.9%) |
Jun 2019 | - | $2.69 M(+10.6%) |
Mar 2019 | - | $2.43 M(+9.8%) |
Dec 2018 | $11.07 M(-20.8%) | $2.21 M(-40.3%) |
Sep 2018 | - | $3.71 M(+39.6%) |
Jun 2018 | - | $2.65 M(+6.2%) |
Mar 2018 | - | $2.50 M(-29.1%) |
Dec 2017 | $13.98 M(-7.1%) | $3.53 M(+47.8%) |
Sep 2017 | - | $2.39 M(-51.6%) |
Jun 2017 | - | $4.92 M(+56.4%) |
Mar 2017 | - | $3.15 M(-25.3%) |
Dec 2016 | $15.06 M(-29.8%) | $4.21 M(+54.3%) |
Sep 2016 | - | $2.73 M(-19.8%) |
Jun 2016 | - | $3.41 M(-27.6%) |
Mar 2016 | - | $4.71 M(-312.4%) |
Dec 2015 | $21.45 M(-33.6%) | -$2.22 M(-128.2%) |
Sep 2015 | - | $7.84 M(+23.6%) |
Jun 2015 | - | $6.35 M(-33.0%) |
Mar 2015 | - | $9.48 M(+49.0%) |
Dec 2014 | $32.32 M(-17.6%) | $6.36 M(-6.5%) |
Sep 2014 | - | $6.80 M(-32.1%) |
Jun 2014 | - | $10.02 M(+9.7%) |
Mar 2014 | - | $9.14 M(-32.0%) |
Dec 2013 | $39.24 M(+39.8%) | $13.44 M(+31.1%) |
Sep 2013 | - | $10.25 M(+19.9%) |
Jun 2013 | - | $8.55 M(+22.0%) |
Mar 2013 | - | $7.00 M(-0.4%) |
Dec 2012 | $28.07 M(+13.6%) | $7.03 M(-22.4%) |
Sep 2012 | - | $9.07 M(+66.5%) |
Jun 2012 | - | $5.45 M(-16.4%) |
Mar 2012 | - | $6.52 M(-27.9%) |
Dec 2011 | $24.70 M(+85.8%) | $9.04 M(+34.4%) |
Sep 2011 | - | $6.73 M(+87.3%) |
Jun 2011 | - | $3.59 M(-32.7%) |
Mar 2011 | - | $5.34 M(+50.2%) |
Dec 2010 | $13.29 M(+62.0%) | $3.55 M(-5.7%) |
Sep 2010 | - | $3.77 M(+41.9%) |
Jun 2010 | - | $2.66 M(-24.8%) |
Mar 2010 | - | $3.53 M(+71.3%) |
Dec 2009 | $8.21 M(+13.2%) | $2.06 M(+3.9%) |
Sep 2009 | - | $1.98 M(-5.8%) |
Jun 2009 | - | $2.11 M(+2.2%) |
Mar 2009 | - | $2.06 M(+48.5%) |
Dec 2008 | $7.25 M | $1.39 M(-47.2%) |
Sep 2008 | - | $2.62 M(+45.6%) |
Jun 2008 | - | $1.80 M(+25.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2008 | - | $1.44 M(-96.1%) |
Dec 2007 | $41.23 M(+499.4%) | $36.82 M(+2872.6%) |
Sep 2007 | - | $1.24 M(-18.8%) |
Jun 2007 | - | $1.53 M(-7.3%) |
Mar 2007 | - | $1.65 M(-13.5%) |
Dec 2006 | $6.88 M(-4.3%) | $1.90 M(+0.5%) |
Sep 2006 | - | $1.89 M(+35.6%) |
Jun 2006 | - | $1.40 M(-17.2%) |
Mar 2006 | - | $1.69 M(-5.6%) |
Dec 2005 | $7.19 M(+28.2%) | $1.79 M(-0.5%) |
Sep 2005 | - | $1.80 M(-15.8%) |
Jun 2005 | - | $2.13 M(+44.5%) |
Mar 2005 | - | $1.47 M(-0.3%) |
Dec 2004 | $5.61 M(+12.2%) | $1.48 M(+15.2%) |
Sep 2004 | - | $1.28 M(-11.3%) |
Jun 2004 | - | $1.45 M(+3.7%) |
Mar 2004 | - | $1.40 M(-0.3%) |
Dec 2003 | $5.00 M(-10.6%) | $1.40 M(+10.8%) |
Sep 2003 | - | $1.26 M(+9.0%) |
Jun 2003 | - | $1.16 M(-1.2%) |
Mar 2003 | - | $1.17 M(-13.0%) |
Dec 2002 | $5.59 M(+71.0%) | $1.35 M(-2.6%) |
Sep 2002 | - | $1.38 M(-4.0%) |
Jun 2002 | - | $1.44 M(+3.8%) |
Mar 2002 | - | $1.39 M(+40.3%) |
Dec 2001 | $3.27 M(-4.8%) | $990.80 K(+43.1%) |
Sep 2001 | - | $692.20 K(+0.4%) |
Jun 2001 | - | $689.50 K(+7.0%) |
Mar 2001 | - | $644.50 K(-35.4%) |
Dec 2000 | $3.43 M(-65.9%) | $998.00 K(+51.2%) |
Sep 2000 | - | $660.00 K(-6.0%) |
Jun 2000 | - | $702.00 K(-34.6%) |
Mar 2000 | - | $1.07 M(-53.3%) |
Dec 1999 | $10.07 M(-69.4%) | - |
Jun 1999 | - | $2.30 M(-14.8%) |
Mar 1999 | - | $2.70 M(-80.1%) |
Dec 1998 | $32.90 M(+6.8%) | $13.60 M(+171.9%) |
Sep 1998 | - | $5.00 M(-10.7%) |
Jun 1998 | - | $5.60 M(-30.0%) |
Mar 1998 | - | $8.00 M(-15.9%) |
Dec 1997 | $30.82 M(+25.3%) | $9.52 M(+44.2%) |
Sep 1997 | - | $6.60 M(-23.3%) |
Jun 1997 | - | $8.60 M(+43.3%) |
Mar 1997 | - | $6.00 M(-30.2%) |
Dec 1996 | $24.60 M(+106.7%) | $8.60 M(+22.9%) |
Sep 1996 | - | $7.00 M(+27.3%) |
Jun 1996 | - | $5.50 M(+37.5%) |
Mar 1996 | - | $4.00 M(+14.3%) |
Dec 1995 | $11.90 M(-5.6%) | $3.50 M(+20.7%) |
Sep 1995 | - | $2.90 M(+3.6%) |
Jun 1995 | - | $2.80 M(-6.7%) |
Mar 1995 | - | $3.00 M(-34.8%) |
Dec 1994 | $12.60 M(+425.0%) | $4.60 M(+53.3%) |
Sep 1994 | - | $3.00 M(+275.0%) |
Jun 1994 | - | $800.00 K(-20.0%) |
Mar 1994 | - | $1.00 M(-129.4%) |
Dec 1993 | $2.40 M(-20.0%) | -$3.40 M(-247.8%) |
Sep 1993 | - | $2.30 M(+9.5%) |
Jun 1993 | - | $2.10 M(+50.0%) |
Mar 1993 | - | $1.40 M(+27.3%) |
Dec 1992 | $3.00 M | $1.10 M(+22.2%) |
Sep 1992 | - | $900.00 K |
FAQ
- What is Navidea Biopharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual operating expenses year-on-year change?
- What is Navidea Biopharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly operating expenses year-on-year change?
What is Navidea Biopharmaceuticals annual total operating expenses?
The current annual operating expenses of NAVB is $13.93 M
What is the all time high annual operating expenses for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual total operating expenses is $41.23 M
What is Navidea Biopharmaceuticals annual operating expenses year-on-year change?
Over the past year, NAVB annual total operating expenses has changed by +$1.83 M (+15.08%)
What is Navidea Biopharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of NAVB is $2.13 M
What is the all time high quarterly operating expenses for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly total operating expenses is $36.82 M
What is Navidea Biopharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, NAVB quarterly total operating expenses has changed by -$296.40 K (-12.21%)